Prof. Dr Selvaraj Kunjiappan: Professor at Sethu Institute of Technology, India
Dr. K. Selvaraj is a highly experienced researcher and academician in the field of Biotechnology, specializing in Biochemical Engineering. With more than 15 years of research and teaching experience, he is currently a Professor in the Department of Biotechnology at Kalasalingam Academy of Research and Education, Tamil Nadu, India. His research interests span the synthesis of novel drug-loaded nanoparticles for targeted therapies aimed at treating complex diseases such as cancer, diabetes, and neurological disorders. Dr. Selvaraj is committed to advancing the understanding of cellular signaling pathways, genetic network analysis, and the development of natural product-based drug delivery systems. Recognized as one of the world’s top 2% scientists, he has contributed significantly to scientific research, publishing extensively and working on multiple interdisciplinary projects.
Online Profiles
Citations & Metrics
Dr. Selvaraj’s scholarly impact is evident from his impressive citation metrics:
-
Total Citations: 2,588 (Previous: 2,399)
-
h-index: 29 (Previous: 27)
-
i10-index: 69 (Previous: 66)
These metrics reflect the significant influence of his research within his field, showcasing both the volume and the quality of his work over time. His growing h-index and i10-index are a testament to the enduring relevance and impact of his contributions in areas like drug delivery systems, cancer research, and computational biology.
Education
Dr. Selvaraj’s academic journey is marked by multiple post-doctoral fellowships and a solid educational foundation in Biotechnology and Chemical Engineering:
-
Post-Doctoral Research Fellow (Biological Sciences & Bioengineering), Indian Institute of Technology Roorkee, India (2024-2025).
-
Post-Doctoral Research Fellow (Biological Chemistry), University of Warsaw, Poland (2015).
-
Ph.D. in Chemical Engineering, Jadavpur University, Kolkata, India (2016).
-
M. Tech. in Industrial Biotechnology, Bharath Institute of Higher Education and Research, Chennai, India (2006).
-
B. Pharmacy, Tamil Nadu Dr. M.G.R. Medical University, Chennai, India (1999).
His academic background has been pivotal in shaping his interdisciplinary research in biotechnology, pharmacology, and drug delivery systems, further reinforcing his expertise in both theoretical and applied science.
Research Focus
Dr. Selvaraj’s research is centered on developing novel drug delivery systems using biodegradable nanoparticles to improve therapeutic outcomes for diseases such as cancer, diabetes, and Alzheimer’s. His work in drug-loaded nanoparticles aims at achieving better drug stability, bioavailability, and targeting efficiency. Additionally, he investigates the molecular mechanisms underlying various diseases by studying cellular signaling pathways and gene expression regulation. Another key area of his research involves discovering and utilizing bioactive molecules from natural sources for their potential in drug design and development, focusing on the molecular modeling of these compounds for therapeutic applications. Dr. Selvaraj’s innovative research continues to contribute toward advancements in targeted therapy, nanomedicine, and disease-specific drug discovery.
Experience
Dr. Selvaraj has an extensive academic and industrial experience that spans across multiple institutions and research environments:
-
Professor, Department of Biotechnology, Kalasalingam Academy of Research and Education, Tamil Nadu, India (2025-present).
-
Assistant Professor, Department of Biotechnology, Kalasalingam Academy of Research and Education, Tamil Nadu, India (2016-2025).
-
Lecturer, Department of Biotechnology, Rajalakshmi Engineering College, Chennai, India (2009-2012).
-
Lecturer, Department of Biotechnology, VMKV Engineering College, Salem, India (2006-2009).
-
Production Chemist, RPG Life Sciences Ltd. & Sun Pharma Ltd., Gujarat, India (1999-2004).
Throughout his career, Dr. Selvaraj has seamlessly integrated teaching and research, mentoring students and guiding several research projects at both undergraduate and postgraduate levels. His prior industry experience further complements his academic career, where he has worked in pharmaceutical production and quality control.
Research Timeline
Dr. Selvaraj’s career timeline highlights his significant contributions to research and development:
-
2016: Completed Ph.D. in Chemical Engineering, focusing on drug delivery systems and nanoparticle synthesis.
-
2015-2016: Postdoctoral research at the University of Warsaw, exploring biological chemistry and its applications in drug design.
-
2020-2025: Ongoing research at Kalasalingam Academy of Research and Education on nanoparticle-based drug delivery, cancer therapy, and diabetes management.
-
2024-2025: Postdoctoral research in Biological Sciences and Bioengineering at IIT Roorkee, focusing on interdisciplinary applications of biotechnology and bioengineering techniques.
Dr. Selvaraj’s research continues to evolve, with his current focus on the development of advanced nanomedicine and the exploration of cellular pathways in chronic diseases.
Awards & Honors
Dr. Selvaraj has received numerous prestigious awards throughout his career for his exceptional contributions to research and education:
-
Top 2% Scientists List (Stanford University & Elsevier, 2023 & 2024).
-
Erasmus Mundus Post-Doctoral Fellowship, University of Warsaw (2015).
-
INSA Visiting Scientist at IIT Roorkee (2020).
-
TEQIP Ph.D. Fellowship, Government of India (2013).
These accolades reflect his outstanding research achievements and his dedication to advancing scientific knowledge in the field of biotechnology.
Recent Publication
Dr. Selvaraj has made significant contributions to scientific literature, with recent publications in high-impact journals:
-
Targeted Delivery of Thymoquinone-Encapsulated Polyethyleneimine/Poly (Lactic Acid) Nanoparticles into Breast Cancer Cells
JS Pandi, P Pavadai, E Babkiewicz, T Panneerselvam, P Maszczyk, et al.
2025
This study investigates the targeted delivery of thymoquinone, a potent anticancer agent, encapsulated in nanoparticles to enhance the therapeutic efficacy in breast cancer treatment. -
Computational Discovery of Plant-Derived Flavonoids as Potential Amyloid-β Fibril Disaggregating Agents for Alzheimer’s Disease
UL Rakesh, GA Kumar, T Panneerselvam, P Pavadai, S Veerachamy, et al.
Brain Disorders 18, 100233, 2025
This research presents computational methods for identifying plant-derived flavonoids that could aid in Alzheimer’s treatment by disrupting amyloid-β fibrils. -
Network Analysis and In Silico Molecular Modeling of Bioactive Compounds from Sida cordifolia Against NMDA Receptor
CC Murali, S Kunjiappan, S Murugesan, SRK Pandian, T Kathiresan, et al.
Journal of Computational Biophysics and Chemistry 24 (03), 307-318, 2025
A comprehensive study using in silico methods to model bioactive compounds derived from Sida cordifolia and their potential for modulating the NMDA receptor, which plays a crucial role in neurodegenerative diseases. -
Targeting the PI3K Pathway: Advancements and Achievements in Breast Cancer Therapy
BGH Dinesh, SK Bandral, NM Sadashivappa, S Ganjipete, DN Ammunje, et al.
Current Pharmaceutical Design, 2025
This review provides an in-depth overview of the PI3K signaling pathway and its targeted therapies, particularly in the context of breast cancer treatment. -
Elevated Temperature Enhances Task Performance by Improving Cognitive Abilities in Common Rudd (Scardinius erythrophthalmus)
M Sysiak, E Babkiewicz, ML Zebrowski, K Rutkowska, S Kunjiappan, et al.
Scientific Reports 15 (1), 7662, 2025
A novel study exploring how temperature changes can impact cognitive performance in fish, with potential implications for behavioral neuroscience. -
Pharmacokinetics and Brain Tumor Delivery Studies of Thymoquinone-Encapsulated Eudragit L100-Coated Solid-Lipid Nanoparticles
J Senthamarai Pandi, P Pavadai, LM Sundar, M Sankaranarayanan, et al.
Journal of Cluster Science 36 (1), 26, 2025
This article investigates the pharmacokinetics and brain tumor-targeting potential of thymoquinone-loaded solid lipid nanoparticles, a promising delivery system for cancer therapy. -
Surface Receptor-Targeted Protein-Based Nanocarriers for Drug Delivery: Advances in Cancer Therapy
P Theivendren, P Pavadai, S Veerachamy, P Palanisamy, S Kunjiappan
Nanotechnology 36 (12), 122003, 2025
A review on the development of protein-based nanocarriers and their specific applications in targeting cancer cells for improved drug delivery. -
Folic Acid-Conjugated Ferulic Acid-Entangled Single-Walled Carbon Nanotubes: A Targeted Therapeutic Approach for Effective Breast Cancer Treatment
Journal of Drug Delivery Science and Technology 107111 (2), 1-22, 2025
This study explores the use of folic acid-conjugated carbon nanotubes for targeted drug delivery in breast cancer, enhancing the effectiveness of treatment. -
Cellulase from Halomonas elongata for Biofuel Application: Enzymatic Characterization and Inhibition Tolerance Investigation
MD Narayanan A, Jeyaram K, Prabhu AA, Krishnan S, Kunjiappan S, Baskaran N
Preparative Biochemistry and Biotechnology 1 (1), 1-20, 2025
A detailed investigation into the enzymatic properties of cellulase from Halomonas elongata and its potential applications in biofuel production.